44 related articles for article (PubMed ID: 23714650)
1. Efficacy of combined therapy of goserelin and letrozole on very young women with advanced breast cancer as first-line endocrine therapy.
Liu X; Qu H; Cao W; Wang Y; Ma Z; Li F; Wang H
Endocr J; 2013; 60(6):819-28. PubMed ID: 23714650
[TBL] [Abstract][Full Text] [Related]
2. The role of hormonal therapy in patients with relapsed high-grade ovarian carcinoma: a retrospective series of tamoxifen and letrozole.
George A; McLachlan J; Tunariu N; Della Pepa C; Migali C; Gore M; Kaye S; Banerjee S
BMC Cancer; 2017 Jun; 17(1):456. PubMed ID: 28666422
[TBL] [Abstract][Full Text] [Related]
3. Feasibility trial of letrozole in combination with bevacizumab in patients with metastatic breast cancer.
Traina TA; Rugo HS; Caravelli JF; Patil S; Yeh B; Melisko ME; Park JW; Geneus S; Paulson M; Grothusen J; Seidman AD; Fornier M; Lake D; Dang C; Robson M; Theodoulou M; Flombaum CD; Norton L; Hudis CA; Dickler MN
J Clin Oncol; 2010 Feb; 28(4):628-33. PubMed ID: 19841327
[TBL] [Abstract][Full Text] [Related]
4. Subcutaneous testosterone-letrozole therapy before and concurrent with neoadjuvant breast chemotherapy: clinical response and therapeutic implications.
Glaser RL; York AE; Dimitrakakis C
Menopause; 2017 Jul; 24(7):859-864. PubMed ID: 28195993
[TBL] [Abstract][Full Text] [Related]
5. RAZOR: A Phase II Open Randomized Trial of Screening Plus Goserelin and Raloxifene Versus Screening Alone in Premenopausal Women at Increased Risk of Breast Cancer.
Howell A; Ashcroft L; Fallowfield L; Eccles DM; Eeles RA; Ward A; Brentnall AR; Dowsett M; Cuzick JM; Greenhalgh R; Boggis C; Motion J; Sergeant JC; Adams J; Evans DG
Cancer Epidemiol Biomarkers Prev; 2018 Jan; 27(1):58-66. PubMed ID: 29097444
[No Abstract] [Full Text] [Related]
6. Everolimus, Letrozole, and Metformin in Women with Advanced or Recurrent Endometrioid Endometrial Cancer: A Multi-Center, Single Arm, Phase II Study.
Soliman PT; Westin SN; Iglesias DA; Fellman BM; Yuan Y; Zhang Q; Yates MS; Broaddus RR; Slomovitz BM; Lu KH; Coleman RL
Clin Cancer Res; 2020 Feb; 26(3):581-587. PubMed ID: 31628143
[TBL] [Abstract][Full Text] [Related]
7. Relapsing eosinophilic pneumonia in a patient with recurrent breast cancer receiving abemaciclib plus endocrine therapy.
Ogata H; Koga C; Yanagihara T; Moriuchi Y; Enokizu-Ogawa A; Ishimatsu A; Otsuka J; Taguchi K; Moriwaki A; Tokunaga E; Yoshida M
Respirol Case Rep; 2024 Mar; 12(3):e01320. PubMed ID: 38455504
[TBL] [Abstract][Full Text] [Related]
8. Correction: Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care - The PreFace Study.
Hack CC; Maass N; Aktas B; Kümmel S; Thomssen C; Wolf C; Kolberg HC; Brucker C; Janni W; Dall P; Schneeweiss A; Marme F; Ruebner M; Theuser AK; Hofmann NM; Böhm S; Almstedt K; Kellner S; Nabieva N; Gass P; Sütterlin MW; Lück HJ; Schmatloch S; Kalder M; Uleer C; Juhasz-Böss I; Hanf V; Jackisch C; Müller V; Rack B; Belleville E; Wallwiener D; Rody A; Rauh C; Bayer CM; Uhrig S; Goossens C; Huebner H; Brucker SY; Häberle L; Fehm TN; Hein A; Fasching PA
Geburtshilfe Frauenheilkd; 2024 Feb; 84(2):e10. PubMed ID: 38690326
[TBL] [Abstract][Full Text] [Related]
9. The Growing Role of CDK4/6 Inhibitors in Treating Hormone Receptor-Positive Advanced Breast Cancer.
Shah AN; Cristofanilli M
Curr Treat Options Oncol; 2017 Jan; 18(1):6. PubMed ID: 28197838
[TBL] [Abstract][Full Text] [Related]
10. Palbociclib and Letrozole in Advanced Breast Cancer.
Finn RS; Martin M; Rugo HS; Jones S; Im SA; Gelmon K; Harbeck N; Lipatov ON; Walshe JM; Moulder S; Gauthier E; Lu DR; Randolph S; Diéras V; Slamon DJ
N Engl J Med; 2016 Nov; 375(20):1925-1936. PubMed ID: 27959613
[TBL] [Abstract][Full Text] [Related]
11. One-Year Neoadjuvant Endocrine Therapy in Breast Cancer.
Rusz O; Vörös A; Varga Z; Kelemen G; Uhercsák G; Nikolényi A; Ormándi K; Simonka Z; Kahán Z
Pathol Oncol Res; 2015 Sep; 21(4):977-84. PubMed ID: 25753983
[TBL] [Abstract][Full Text] [Related]
12. Ten years disease-free survival after solitary brain metastasis from breast cancer.
Nieder C; Walter K; Nestle U; Schnabel K
J Cancer Res Clin Oncol; 1996; 122(9):570-2. PubMed ID: 8781573
[TBL] [Abstract][Full Text] [Related]
13. Long-term survival after brain metastases in breast cancer.
Kocher M; Müller RP; Staar S; Degroot D
Strahlenther Onkol; 1995 May; 171(5):290-5. PubMed ID: 7770785
[TBL] [Abstract][Full Text] [Related]
14. Extended therapy with letrozole and ovarian suppression in premenopausal patients with breast cancer after tamoxifen.
Ruddy KJ; DeSantis SD; Barry W; Guo H; Block CC; Borges V; Winer EP; Partridge AH
Clin Breast Cancer; 2014 Dec; 14(6):413-6. PubMed ID: 24970714
[TBL] [Abstract][Full Text] [Related]
15. Adding Ovarian Suppression to Tamoxifen for Premenopausal Breast Cancer: A Randomized Phase III Trial.
Kim HA; Lee JW; Nam SJ; Park BW; Im SA; Lee ES; Jung YS; Yoon JH; Kang SS; Lee SJ; Park KH; Jeong J; Cho SH; Kim SY; Kim LS; Moon BI; Lee MH; Kim TH; Park C; Jung SH; Gwak G; Kim J; Kang SH; Jin YW; Kim HJ; Han SH; Han W; Hur MH; Noh WC;
J Clin Oncol; 2020 Feb; 38(5):434-443. PubMed ID: 31518174
[TBL] [Abstract][Full Text] [Related]
16. OFS plus AI or SERM vs. SERM alone in premenopausal women with hormone receptor-positive breast cancer: a prospective cohort study using the real-world database.
Hu K; He P; Peng Q; Zhong X; Deng L; Xie Y; Li J; Xu H; Lu D; Zheng H
Breast Cancer; 2019 May; 26(3):339-348. PubMed ID: 30367358
[TBL] [Abstract][Full Text] [Related]
17. Phase II Trial of Goserelin and Exemestane Combination Therapy in Premenopausal Women With Locally Advanced or Metastatic Breast Cancer.
Wang J; Xu B; Yuan P; Ma F; Li Q; Zhang P; Cai R; Fan Y; Luo Y; Li Q
Medicine (Baltimore); 2015 Jul; 94(26):e1006. PubMed ID: 26131799
[TBL] [Abstract][Full Text] [Related]
18. Real-world effectiveness of aromatase inhibitors and fulvestrant in HR+/HER2- advanced breast cancer: a snapshot of the last two years before conventional use of CDK 4/6 inhibitors in a Portuguese institution.
Teodoro MI; Mayer A; da Costa Miranda A; Nunes H; da Costa FA; Lourenço A
J Pharm Policy Pract; 2024; 17(1):2296551. PubMed ID: 38250517
[TBL] [Abstract][Full Text] [Related]
19. Aromatase inhibitors in premenopausal women with breast cancer: the state of the art and future prospects.
Pistelli M; Mora AD; Ballatore Z; Berardi R
Curr Oncol; 2018 Apr; 25(2):e168-e175. PubMed ID: 29719441
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
